Calyxt completes registered direct offering of Common Stock
Client(s) Calyxt, Inc.
Jones Day advised Calyxt, Inc., a plant-based technology company, in connection with its registered direct offering of 3,750,000 shares of Common Stock. Cellectis S.A., the Company’s majority shareholder, purchased 1,250,000 shares in the offering.